维普中文期刊产品整合服务
36篇 您的检索式:作者名="Dirim"
    题名 作者 年代 出处 被引量
1玻璃体内注射贝伐单抗对DME患者视力、黄斑中心厚度和眼血流的影响(英文)显示文摘目的:探讨玻璃体内注射贝伐单抗对伴有黄斑水肿的糖尿病患者眼血流参数的影响。方法:患者21例21眼,伴有弥漫性糖尿病性黄斑水肿(diabeticmacular edema,DME),黄斑中心厚度(central macularthickness,CMT)>320μm,无缺血性黄斑水肿或其他血管性视网膜疾病。患者术前以及注射1.25mg/0.05mL贝伐单抗1d,4wk后接受三种眼科检查:视力(visual acuity,VA)检测、光学相干断层扫描(optical coherence tomography,OCT)测量CMT以及采用超声成像测量眼动脉(ophthalmicartery,OA)、视网膜中央动脉(central retinal artery,CRA)、鼻侧睫状后动脉(nasal posterior ciliary artery,NPCA)以及颞侧睫状后动脉(temporal posterior ciliary artery,TPCA)中的收缩期峰值血流速度(peak systolic velocities,PSV)和舒张末期血流速度(end-diastolic velocities,EDV)。阻力指数(resistive indices,RI)由软件自动计算,注射前与注射后1d的血流速度进行了比较。患者术前和注射后4wk的VA和CMT值进行了比较。结果:注射前平均最佳矫正视力(best-corrected visual acuity,BCVA)为0.88±0.21logMAR,注射后为0.54±0.19logMAR(P<0.01)。平均CMT由注射前440.57±54.58μm下降至250.33±31.12μm(-190.24±36.00μm)。PSV、EDV和RI的变化并不显著。结论:贝伐单抗注射后视力显着改善,CMT降低,而PSV、EDV和RI在OA、CRA、TPCA和NPCA中没有显著变化。玻璃体内注射贝伐单抗注射液能改善VA和CMT,但对于糖尿病患者的OA、CRA、TPCA和NPCA的血流速度没有影响。Mehmet Demir Alper Ozel Burcu Dirim Erhan Ozdal Efe Can 2013国际眼科杂志2013,13,3:2
2Comparison of the effects of intravitreal bevacizumab and triamcinolone acetonide in the treatment of macular edema secondary to central retinal vein occlusion 显示文摘Demir M Dirim B Acar Z 2014Indian J Ophthalmol2014,62,:1
3Traumatic posterior fossa hematomas 显示文摘Dirim BV Oruke C Erdogan N 2005Diagn Interv Radiol2005,11,1:1
4VEGF, COX-2, and PCNA expression in renal cell carcinoma subtypes and their prognostic value显示文摘Dirim A Haberal AN Goren MR 2008Int Urol Nephrol2008,40,4:1
5Renal transplantation experience following endoscopic treatment of vesieoureteral reflux显示文摘Aygun C Ozer C Dirim A 2004Transplant Proc2004,36,1:1
6VEGF, COX2 and PCNA expression in renal cell carcinoma subtypes and their prognositic value显示文摘Dirim A Haberal AN Goren MR 2008Int Urol Nephrol2008,40,4:1
7Labial fusion causing urinary incontinence and recurrent urinary tract infection in a postmenopausal female: a ease report 显示文摘Dirim A Hasirci E 2011Int Uronecol J2011,22,:1
8VEGF,COX-2 and PCNA expression in renal cell subtypes and their prognostic value显示文摘Dirim A Haberal A N Goren M R 2008Int UroNephrol2008,40,4:1
9Methylation reprogramming and chromosomal aneuploidy in vivo fertilized and cloned rabbit preimplantation embryos显示文摘Shi W Dirim F Wolf E 2004Biol Reprod2004,71,:1
10Traumatic posterior fossa hematomas 显示文摘Dirim BV Oriik C Erdogan N 2005Diagn Interv Radiol2005,11,1:1
11Tekin MI,VEGF,COX-2,and PCNA expression in renal cell carcinoma subtypes and their prognostic value显示文摘Dirim A Haberal AN Goren MR 2008Int Urol Nephrol2008,40,4:1
12VEGF,COX-2,and PCNA expression in renal cell carcinoma subtypes and their prog-nostic value 显示文摘Dirim A Haberal A N Goren M R 2008Int Urol Nephrol2008,40,4:1
13Traumatic poste- rior fossa hematomas显示文摘Dirim BV Omkc C Erdogan N 2005Diagn Interv Radrol2005,11,1:1
14Cental macular thickness in patients with type 2 diabetes mellitus without clinical retinopathy显示文摘Demir M Dirim B Acar Z 2013J Ophthalmol2013,13,11:1
15Traumatic Posterior Fossa hematomas 显示文摘Dirim BV Omkc C Erdogan N 2005Diagn lnterv Radiol2005,11,1:1
16VEGF,COX-2,and PCNA expression in renal cell carcinoma subtypes and their prognostic value显示文摘Dirim A Haberal AN Goren MR 2008Int Urol Nephrol2008,40,4:1
17Analysis of Viscosity Values During Mixing and Compaction 显示文摘YIL DIRIM Y JASON H 2003North Central Superpave Center News2003,4,1:1
18VEGF, COX-2, and PCNA expression in renal cell carcinoma subtypes and their prognostic value显示文摘Ayhan Dirim Asuman Nihan Haberal Mehmet Resit Goren Mehmet Ilteris Tekin Levent Peskircioglu Beyhan Demirhan Hakan Ozkardes 2008International Urology and Nephrology2008,,4:1
19Comparison of Medpor coated tear drainage tube versus silicon tear drainage tube in conjunctivodacryoeystorhinostomy:problems and solutions显示文摘Sendul SY Cagatay HH Dirim B 2014Sei- entificWorldJournal2014,2014,16:1
20Traumatik Posterior Fossa Hematomas显示文摘Dirim BV Omke C Erdogan N 2005Diagn Interv Radiol2005,11,14:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费